elliptinium acetate has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernadou, J; Cros, S; Gillet, B; Guittet, E; Ha, T; Meunier, B; Meunier, G; Pratviel, G | 1 |
| Honda, T; Inoue, M; Kato, M; Nakanishi, T; Noguchi, T; Shima, K; Shimamoto, T; Yoshida, T | 1 |
| Belleney, J; Le Pecq, JB; Lescot, E; Markovits, J; Muzard, G; Roques, BP | 1 |
| Atassi, G; Bisagni, E; Guilbaud, N; Jasztold-Howorko, R; Kraus-Berthier, L; Landras, C; Léonce, S; Pierré, A; Prost, JF; Rolland, Y | 1 |
4 other study(ies) available for elliptinium acetate and Leukemia L 1210
| Article | Year |
|---|---|
Ribose as the preferential target for the oxidized form of elliptinium acetate in ribonucleos(t)ides. Biological activities of the resulting adducts.
Topics: Alkaloids; Alkylation; Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Ellipticines; Leukemia L1210; Mice; Ribonucleosides; Ribonucleotides; Ribose | 1986 |
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
Topics: Alkaloids; Animals; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Ellipticines; Glycosides; Leukemia L1210; Leukemia P388; Melanoma; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma 180; Structure-Activity Relationship | 1988 |
Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cattle; Chemical Phenomena; Chemistry; DNA; Ellipticines; Intercalating Agents; Leukemia L1210; Magnetic Resonance Spectroscopy | 1986 |
Synthesis and evaluation of 9-hydroxy-5-methyl-(and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N- [(dialkylamino)alkyl]carboxamides, a new promising series of antitumor olivacine derivatives.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Survival; Colonic Neoplasms; Ellipticines; Leukemia L1210; Mice; Neoplasm Transplantation; Tumor Cells, Cultured | 1994 |